These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients. Dedinská I; Graňák K; Vnučák M; Skálová P; Laca Ĺ; Krivuš J; Galajda P; Mokáň M Transplant Proc; 2019 Dec; 51(10):3259-3264. PubMed ID: 31732198 [TBL] [Abstract][Full Text] [Related]
4. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Deeks ED; Keating GM Drugs; 2009 Jul; 69(11):1483-512. PubMed ID: 19634926 [TBL] [Abstract][Full Text] [Related]
5. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation. Alloway RR; Woodle ES; Abramowicz D; Segev DL; Castan R; Ilsley JN; Jeschke K; Somerville KT; Brennan DC Am J Transplant; 2019 Aug; 19(8):2252-2261. PubMed ID: 30838775 [TBL] [Abstract][Full Text] [Related]
6. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. Tanriover B; Jaikaransingh V; MacConmara MP; Parekh JR; Levea SL; Ariyamuthu VK; Zhang S; Gao A; Ayvaci MUS; Sandikci B; Rajora N; Ahmed V; Lu CY; Mohan S; Vazquez MA Clin J Am Soc Nephrol; 2016 Sep; 11(9):1650-1661. PubMed ID: 27364616 [TBL] [Abstract][Full Text] [Related]
7. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience. Huang HF; Zhou JY; Xie WQ; Wu JY; Deng H; Chen JH Int Urol Nephrol; 2016 Aug; 48(8):1363-1370. PubMed ID: 27170340 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death. Peng W; Liu G; Xie W; Huang H; Wu J; Shou Z; Chen J Int J Clin Pract Suppl; 2015 May; (183):23-8. PubMed ID: 26177071 [TBL] [Abstract][Full Text] [Related]
10. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin. Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Doares W; Kaczmorski S; Farney AC Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622 [TBL] [Abstract][Full Text] [Related]
11. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971 [TBL] [Abstract][Full Text] [Related]
12. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149 [TBL] [Abstract][Full Text] [Related]
13. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study. Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282 [TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction . Descourouez JL; Jorgenson MR; Parajuli S; Mandelbrot DA; Leverson GE; Odorico JS; Redfield RR Clin Nephrol; 2020 Feb; 93(2):77-84. PubMed ID: 31670651 [TBL] [Abstract][Full Text] [Related]
16. Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome. Kesiraju S; Paritala P; Rao Ch UM; Athmakuri SM; Reddy VS; Sahariah S Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):9-15. PubMed ID: 24434376 [TBL] [Abstract][Full Text] [Related]
17. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation. Flaman F; Zieroth S; Rao V; Ross H; Delgado DH J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of antibody induction therapy in the current era of kidney transplantation. Opelz G; Unterrainer C; Süsal C; Döhler B Nephrol Dial Transplant; 2016 Oct; 31(10):1730-8. PubMed ID: 27190386 [TBL] [Abstract][Full Text] [Related]
20. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial. Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]